GSA Capital Partners »

ADC Therapeutics SA shares owned by GSA Capital Partners

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $74k 21k 3.54
2023-09-30 $109k 122k 0.89
2023-06-30 $234k 109k 2.15
2023-03-31 $46k 24k 1.95

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding ADC Therapeutics SA

Redmile Group
Prosight Management
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
BlackRock
Eventide Asset Management
Goldman Sachs Group
State Street Corporation
TCG Crossover Management
Lynx1 Capital Management
Vanguard Group
Geode Capital Management
Platinum Investment Mangement
Citadel Advisors

View all funds holding ADC Therapeutics SA